Hello,

I would expect novel antivirals (e.g. sofosbuvir) to have a an emerging role in this area. There is a nice article here that summarizes some of these issues:

http://www.hcvguidelines.org/full-report/unique-patient-populations-post-liver-transplantation-box-summary-recommendations

Dr. Jordan Weinstein